SCHEMBL8353063

SCHEMBL8353063

CCOC(=O)N1CCC(N2CCC(O)CC2)CC1

nearest known ligand 0.70

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 4/20 0.70
TP53 P04637 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
GAA P10253 2/20 0.54
MAPK1 P28482 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
ALOX12 P18054 1/20 0.53
CHRM2 P08172 4/20 0.52
CHRM4 P08173 2/20 0.52
CHRM3 P20309 2/20 0.52
CHRM5 P08912 1/20 0.52
ALDH1A1 P00352 4/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
KDM4E B2RXH2 2/20 0.50
THRB P10828 1/20 0.50
ATM Q13315 1/20 0.50
NOS3 P29474 1/20 0.48
NOS2 P35228 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1219954 0.89 GAA (0.65) CHRM1TP53TDP1GAASMN1; SMN2
SCHEMBL12967015 0.85 MAPK1 (0.70) CHRM1TP53TDP1GAAMAPK1
SCHEMBL14810258 0.84 CHRM1 (0.76) CHRM1TP53TDP1GAAMAPK1
SCHEMBL14810985 0.84 CHRM1 (0.76) CHRM1TP53TDP1GAAMAPK1
SCHEMBL18849447 0.83 GAA (0.57) CHRM1TP53TDP1GAASMN1; SMN2
SCHEMBL4863171 0.83 GAA (0.57) CHRM1TP53TDP1GAASMN1; SMN2
SCHEMBL11178916 0.82 CHRM1 (0.64) CHRM1TP53TDP1GAAMAPK1
SCHEMBL8486938 0.82 CHRM1 (0.64) CHRM1TP53TDP1GAAMAPK1
SCHEMBL18114692 0.82 TSHR (0.67) CHRM1TP53TDP1GAAMAPK1
SCHEMBL8490717 0.81 CHRM1 (0.56) CHRM1TP53TDP1MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999032443-A1 MUSCARINIC AGENTS AND USE THEREOF TO TREAT GLAUCOMA, MYOPIA, AND VARIOUS OTHER CONDITIONS ALCON LABORATORIES, INC. (US) 1999-07-01 WO disclosed